Home › Multipel myeloom › New York › Queens
Multipel myeloom klinische studies in Queens, NY
20 studies voor Multipel myeloom zoeken deelnemers op locaties in en rond Queens (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RekruterenFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mijl verwijderd
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 3
- NYU Winthrop, Mineola · 11 mijl verwijderd
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruterenFase 3
- Northwell Health Cancer Institute, Lake Success · 9 mijl verwijderd
- NYU Langone Hospital Long Island, Mineola · 11 mijl verwijderd
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RekruterenFase 3
- MSK Nassau, Uniondale · 13 mijl verwijderd
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Queens Cancer Center, Rego Park · 3 mijl verwijderd
- Cohen Children's Medical Center, New Hyde Park · 9 mijl verwijderd
- Northwell Health Monter Cancer Center, Lake Success · 9 mijl verwijderd
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RekruterenFase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mijl verwijderd
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruterenFase 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mijl verwijderd
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mijl verwijderd
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RekruterenFase 3
- MSK Nassau, Uniondale · 13 mijl verwijderd
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RekruterenFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruterenFase 3
- Research Site, New Hyde Park · 9 mijl verwijderd
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RekruterenObservatieonderzoek
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mijl verwijderd
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RekruterenFase 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RekruterenFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RekruterenFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekruterenFase 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mijl verwijderd
A Dietary Study for People With Multiple Myeloma
Rekruteren
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RekruterenFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mijl verwijderd
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mijl verwijderd
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Rekruteren
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mijl verwijderd
Multipel myeloom studies in andere steden
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Andere studies in Queens
- Borstkanker63 studies
- Niet-kleincellige longkanker49 studies
- Colorectale kanker31 studies
- Metastatische kanker28 studies
- Eierstokkanker28 studies
- Prostaatkanker27 studies
- Kanker (alle vormen)26 studies
- Endometriumkanker25 studies
- Longkanker22 studies
- Acute myeloïde leukemie21 studies
- Plaveiselcelcarcinoom van hoofd en hals20 studies
- Aldermeesklierkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.